For the first time, the World Health Organization has formally recommended GLP-1 drugs as part of long-term obesity treatment for adults.
Published Monday in JAMA, the new WHO guidelines mark a significant shift in the agency’s historical stance — moving from an emphasis on diet and physical activity alone to acknowledging obesity as a complex, chronic disease that may require medication as part of sustained treatment.
The George Washington University has experts available for interviews on this topic. If you are interested in scheduling an interview with a GW expert please contact Katelyn Deckelbaum, katelyn [dot] deckelbaum
gwu [dot] edu (katelyn[dot]deckelbaum[at]gwu[dot]edu).
William Dietz is the director of the Sumner M. Redstone Global Center for Prevention and Wellness at the GW Milken Institute School of Public Health.
Christine Gordon is an associate professor of Medicine at the GW School of Medicine and Health Sciences. She is also a physician in the GW weight loss clinic.
-GW-